4-(Aminomethyl)tetrahydro-2H-pyran-4-ol hydrochloride, 95.0%, 10g

Sel tripotassique EDTA, min 99%, 250 g, emballage plastique.

2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide, 95.0%, 250mg

3-FLUORO-3-METHYLAZEPANE HCL, 95.0%, 250mg

(5-AMINO-2-(METHOXYCARBONYL)PYRIDIN-4-YL)BORONIC ACID PINACOL ESTER, 95.0%, 1g

p-Tolualdehyde 2,4-Dinitrophenylhydrazone>98.0%(T)(HPLC)10g

2-Amino-1-(3-bromo-phenyl)-ethanone; hydrochloride, 95.0%, 5g

N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide, 98%, 5mg

Azur C (CI 52002), 5 g

2-Ethylmorpholine, 95.0%, 5g

5-Phenyl-1,3,4-oxadiazol-2-ol, 95.0%, 5g

Ethyl 5-bromonicotinate, 98.0%, 100g

2-chloro-6-(1H-1,2,3,4-tetrazol-5-yl)aniline, 97, 250mg